Urotensin-II (UII),
U ROTENSIN-II (UII) is a potent vasoconstrictor peptide
originally isolated from fish spinal cords (1) . Its human homolog has subsequently been cloned and characterized (2) . The predicted human urotensin II (hUII) consists of 11 amino acid residues with a cyclic hexapeptide conserved among many species. Although the vasoconstrictive potency of hUII on rat thoracic aorta is greater than that of any other known peptides, it shows differential vasoconstrictor responses in various blood vessels of many species, suggesting its divergent species and regional differences (3) (4) (5) . hUII has been shown to be an endogenous ligand for an orphan G protein-coupled receptor (GPCR), GPR14 (3, 4, 6, 7) . GPR14 mRNA is exclusively expressed in the neuronal and the cardiovascular tissues (3, 4, 8, 9) .
The expression of UII mRNA in human, rat, and mouse central nervous system was strongest in the medulla oblongata of the brain and the spinal cord (2-4), but hUII mRNA was also detectable in several human peripheral tissues, such as kidney, spleen, and adrenal glands, by dot blot analysis (2) . However, a recent study (4) has revealed, by Northern blot analysis, that hUII mRNA was expressed most abundantly in human kidney, and little, if any, hUII mRNA was expressed in other human peripheral tissues. We have recently confirmed that both hUII and GPR14 mRNAs are more abundantly expressed in human kidney tissues than those in cardiovascular tissues, as quantified by real-time quantitative RT-PCR (10) . Furthermore, we have also demonstrated that significant amounts of hUII are excreted in human urine, possibly secreted from renal tubular cells (10) . However, there is no information yet available as to whether UII is actually produced by and secreted from renal tubular cells.
It has recently been reported that hUII stimulated the proliferation of vascular smooth muscle cells (11) and that the effect was potentiated by oxidized low-density lipoprotein (12) . These data suggest that hUII, in addition to its vasoconstrictive effect, acts as a potent mitogen, which may be involved in the progression of atherosclerosis. However, it remains unknown whether UII has any biological activities on renal tubular cells.
These observations led us to examine whether renal epithelial cells express UII mRNA and secrete UII-like immunoreactivity (LI) and whether UII has any mitogenic action on these cells in an autocrine/paracrine fashion.
Materials and Methods Materials
Synthetic hUII and rabbit polyclonal anti-hUII antibody were obtained from Peptide Institute (Osaka, Japan); PD98059 from New England Biolabs, Inc. (Beverly, MA); GF109203X from Calbiochem-Novabiochem (La Jolla, CA); SB203580, LY294002, and wortmannin from Sigma (St. Louis, MO); nicardipine from Yamonouchi Phermaceutical (Tokyo, Japan); phosphorylated forms of ERK1/ 
Cell culture
LLCPK1 cells were cultured in DMEM containing 10% fetal calf serum at 37 C in a humidified atmosphere of 95% air-5% CO 2 as previously described (13) .
ERK1/2 activity
Cellular ERK1/2 activity was determined as previously described (14, 15) . In brief, quiescent LLCPK1 cells grown on a 12-well plate were stimulated with hUII at 37 C in serum-free DMEM for the indicated times, and the reaction was terminated by the replacement of medium with ice-cold lysis buffer. The sample was centrifuged at 25,000 ϫ g for 20 min at 4 C, and the supernatant was assayed for p42/p44 MAPK activity using an assay kit (Amersham Life Science, Piscataway, NJ).
Western blotting analysis was performed as previously described (14, 16) using cells grown on a six-well plate. SDS-PAGE gels were transferred onto nitrocellulose, which was blocked with Blotto (5% dried nonfat milk in PBS), and incubated with polyclonal phospho-specific MAPK antibody (1:2000) that recognizes ERK1/2 only when catalytically activated by phosphorylation at Tyr 202 /Tyr 204 , or with polyclonal rabbit anti-ERK2 antibody (1:1000) that recognizes both the phosphorylated and nonphosphorylated form, followed by horseradish peroxidase-conjugated antirabbit IgG antiserum. Signals were visualized using the ECL chemiluminescence system (Amersham).
Mitogenic assay

DNA synthesis was assessed by incorporation of [
3 H]thymidine into cells as previously described (14) . In brief, after preincubation with serum-free DMEM for 48 h, the quiescent cells were incubated with hUII for 20 h, after which 1 Ci 
Determination of intracellular calcium concentration ([Ca 2ϩ ] i )
Measurement of [Ca 2ϩ ] i was determined by the Ca 2ϩ -fura-2 fluorescence method as previously described (17) . After incubation in serum-free DMEM for 48 h, cells were trypsinized and incubated with 4 mm fura-2 acetoxymethyl ester (Dojindo Chemical Laboratory, Kumamoto, Japan) at 37 C for 20 min in buffered physiological salt solution. The Ca 2ϩ -fura-2 fluorescence of the suspended cells was measured by a spectrofluorometer (CAF-100, Japan Spectroscopic Co., Tokyo, Japan) using excitation at 340 and 380 nm and emission at 500 nm. [Ca 2ϩ ] i values were determined according to the method of Grynkiewicz et al. (18) .
RT-PCR
Total RNA was extracted from LLCPK1 cells by using RNA zolB (Tel-Test, Friendswood, TX), and cDNA was synthesized with a firststrand cDNA synthesis kit (Amersham Pharmacia Biotech). Amplification of porcine c-myc and UII transcripts was performed using specific primers for c-myc (forward primer, 5Ј-AGAGAAGCTGGCCTCCTACC-3Ј; and reverse primer, 5Ј-GGCGGAGGAGAGCAGAGAGT-3Ј) and UII (forward primer, 5Ј-GGATCTCAGGGAAGCAGATG-3Ј; and reverse primer, 5Ј-GCCCACGTTTCTTGTATGGT-3Ј), respectively. Real-time quantification of porcine c-myc levels in quiescent LLCPK1 cells was performed using LightCycler (Roche Molecular Biochemicals, Mannheim, Germany)-based real-time quantitative RT-PCR essentially as described (10, 17) . TaqStart antibody (CLONTECH Laboratories, Inc., Palo Alto, CA) was used to prevent generation of nonspecific amplification products. The fluorescence data were quantitatively analyzed by using serial dilution of control samples included in each reaction to produce a standard curve. For verification of the melting curve results, the PCRs were examined by 1.5% agarose gel electrophoresis. Conventional RT-PCR of GPR14 mRNA was performed using two sets of primers (forward primer, 5Ј-GCAACCCTCAACAGCTCCTG-3Ј; and reverse primer, 5Ј-AAGTGC-CACTCCTTGGTGAC-3Ј) and (forward primer, 5Ј-TGCTGTACCTGCT-CAGCATC-3Ј; and reverse primer, 5Ј-AAGTCCAGGCCGAAGAGCAC-3Ј), each amplifying a 266-bp and an 81-bp product, respectively.
RIA and extraction
RIA for hUII was performed as previously described (10) . Briefly, samples or standard synthetic hUII (Peptide Institute Inc.) and rabbit anti-hUII serum (final dilution, 1:10,000; Peptide Institute Inc.) were incubated at 4 C for 24 h, followed by the late addition of [ 125 I]-hUII (ϳ10,000 cpm) and further incubation at 4 C for 24 h. Separation of bound from free ligands was performed by the double-antibody method. Serum-free conditioned media from cultured LLCPK1 cells was extracted as previously described (10) . In brief, supernatant acidified with trifluoroacetic acid was loaded onto a Sep-Pak C18 cartridge (Millipore-Waters Inc., Milford, MA), and the adsorbed materials were eluted with 70% acetonitrile/0.1% trifluoroacetic acid. The coefficients of variation of interassay and intraassay were less than 10%.
Statistical analysis
All results are expressed as the mean Ϯ sem. Statistical analysis was performed by Wilcoxon's t test or ANOVA; P Ͻ 0.05 was considered significant. 
Results
Growth
ERK1/2 activation
To determine whether the growth-promoting signal by hUII involves ERK activation, ERK1/2 was determined by immunoblotting with monoclonal antibody that selectively recognizes Tyr 202 /Tyr 204 -ERKs as well as by enzymatic assay. hUII induced a rapid (within 5 min) and transient tyrosine phosphorylation of ERK1/2 (Fig. 3) . hUII also caused a transient ERK1/2 activation, peaking at 5 min, followed by a gradual decline to the basal levels by 30 min (Fig. 4A) . Stimulation of ERK1/2 activity by hUII was dose-dependent (10 Ϫ11 to 10 Ϫ7 m; Fig. 4B ). The effects were completely blocked by PD98059 (10 Ϫ5 m) and GF109203X (10 Ϫ6 m), but not by SB203580 or nicardipine. These data suggest that hUII induced phosphorylation and activation of ERK1/2 via a PKC-dependent manner, independently from PI-3 kinase pathway and Ca 2ϩ influx via dihydropyridine (DHP)-sensitive Ca 2ϩ channels.
Induction of c-myc protooncogene
To examine whether hUII induces protooncogene, c-myc, we quantified c-myc mRNA levels by real-time quantitative RT-PCR. hUII rapidly (within 1 min) and transiently induced c-myc mRNA levels, which peaked after 2 min (Fig. 5) .
Expression of UII mRNA and protein
The extracted conditioned media from LLCPK1 cells by SepPack C18 was subjected to hUII RIA. The dilution curve generated by the extracted media was parallel to that of synthetic hUII (Fig. 6) , suggesting the presence of UII-LI in the media. UII-LI secreted by LLCPK1 cells (10 6 cells) was calculated to be 1.6 ng/24 h. RT-PCR using total RNA from LLCPK1 cells revealed a 142-bp band corresponding to porcine UII transcript (Fig. 7) .
Expression of GPR14 mRNA
RT-PCR using two independent human GPR14 primers revealed a single band corresponding to the size of human GPR14 mRNA (Fig. 7) . Partial sequencing of the amplified products revealed homology to human GPR14, indicating the expression of GPR14 in porcine LLCPK1 cells.
Effect of anti-hUII antibody on mitogenesis
Because the LLCPK1 cell line synthesizes and secretes hUII-LI into culture media, whereas exogenous hUII stimulates DNA synthesis of LLCPK1 cells, we reasoned that UII may function as an autocrine/paracrine growth factor for LLCPK1 cells. Addition of rabbit anti-hUII antiserum (dilution at 1:100) significantly suppressed DNA synthesis of LLCPK1 cells under serum-free condition, whereas the addition of normal rabbit serum (1:100) was without effect (Fig.  8) , suggesting its role as an autocrine/paracrine growthpromoting factor.
Discussion
In the present study, we have shown for the first time that hUII has a potent mitogenic effect on a porcine renal epithelial cell line (LLCPK1). The hUII-stimulated DNA synthesis appears to be mediated via activation of PKC and ERK1/2 as well as Ca 2ϩ influx, because PKC inhibitor (GF109203X), MEK-1 inhibitor (PD98059), and DHP-sensitive calcium-channel antagonist (nicardipine) completely blocked the mitogenic effect by hUII. However, DNA synthesis stimulated by hUII was not inhibited by PI-3 kinase inhibitors (wortmannin and LY294002) or a p38 kinase inhibitor (SB203580), thus excluding the involvement of both p38 kinase and PI-3 kinase in hUII-induced mitogenesis. The present study has further shown that hUII dose-dependently stimulated ERK1/2 activity and increased [Ca 2ϩ ] i in LLCPK1 cells. The mitogenic property of hUII is further strengthened by the result that hUII potently induced c-myc protooncogene, an immediate early response gene related to cell growth and differentiation (19) . Taken together, it is suggested that UII exerts its mitogenic effect on LLCPK1 cells via activation of both PKC and ERK1/2 pathways as well as Ca 2ϩ influx mediated via DHP-sensitive Ca 2ϩ channels. GPR14, a member of an orphan GPCR family, has recently been identified as a specific receptor for UII (3, 4) . Although the porcine GPR14 sequence is not yet available in the databases, we PCR-amplified porcine GPR14 cDNA using human GPR14 primers and confirmed its homology to human GPR14 by sequencing amplified products. Thus, our results indicate that porcine renal epithelial cells (LLCPK1) express GPR14 mRNA with functional UII receptors linked to signal transduction and mitogenic response.
GPR14 has been shown to be coupled to Ca 2ϩ mobilization (3, 4) , but the detailed signaling pathways triggered by UII stimulation have been poorly understood. It has been shown that the hUII-induced arterial smooth muscle contraction is linked to phospholipase C-mediated generation of inositol phosphates (20) as well as activation of the small GTP protein Rho and its downstream effector Rho kinase (11) . Stimulation of PLC and Gq signaling in general is coupled to rapid and transient increase in [Ca 2ϩ ] i , which is usually related to contraction of vascular smooth muscle cells (21, 22) , whereas influx of extracellular Ca 2ϩ leading to sustained increase in [Ca 2ϩ ] i is closely linked to mitogenesis activity (23) . The present study has clearly shown that the sustained influx of extracellular Ca 2ϩ via DHP-sensitive Ca 2ϩ channels by hUII plays pivotal roles in its mitogenic effect in LLCPK1 cells. ERK1/2 is activated by a variety of receptor tyrosine kinases and GPCRs (24) . GPCR agonists, such as angiotensin II (25) and endothelin-1 (26) , can recruit adaptor proteins to induce activation of ras-dependent ERK1/2 in a similar fashion as receptor tyrosine kinases. Alternatively, PKC can activate Raf-1, a MEK-1 kinase, thereby leading to ERK1/2 activation (27) . The present study has clearly demonstrated that both MEK-1 inhibitor (PD98059) and PKC inhibitor (GF109203X) similarly and completely blocked the hUIIstimulated ERK1/2 activity as well as DNA synthesis in LLCPK1 cells. Our data are comparable to those of a recent study (12) showing that hUII-induced proliferation of vas- cular smooth muscle cells is equally blocked by MEK-1 and PKC inhibitors. Taken together, the mitogenic action by UII is most likely mediated via a PKC-dependent ERK1/2 pathway, although its exact signal transduction remains to be determined.
Our present study has provided direct evidence that porcine renal tubular cells (LLCPK1) express UII mRNA, as demonstrated by RT-PCR. Furthermore, the apparent parallelism of the conditioned media to standard hUII in the present RIA suggests that porcine UII secreted from renal epithelial cells is immunologically similar to that of human UII. In fact, LLCPK1 cells (10 6 cells) secrete approximately 1.6 ng UII-LI during 24 h under serum-free conditions; the concentrations (ϳ10 Ϫ9 m) appear to be effective enough to stimulate ERK1/2 activity, increase [Ca 2ϩ ] i , and result in cell proliferation. Finally, the present neutralization experiments have clearly shown that the anti-hUII antibody significantly suppressed DNA synthesis in LLCPK1 cells. These results, in conjunction with the concomitant expression of both UII and GPR14 by the cells, lend strong support to the notion that endogenous UII secreted by renal tubular cells acts on itself and/or the nearby cells as an autocrine/paracrine growth factor.
In our previous study (10) , hUII mRNA was expressed most abundantly in the kidney among certain human tissues examined, a finding that is in agreement with another study showing that the kidney is the major site of its synthesis in humans (4) . It has been reported that several other vasoactive peptides, such as atrial natriuretic peptide (28), endothelin-1 (29) , and adrenomedullin (30) , are excreted in human urine. We have also observed that the urinary hUII clearance exceeds the glomerular filtration rate in normal subjects, and even higher urinary hUII excretion was observed in patients with renal tubular disorders (10), suggesting the impaired reabsorption and/or the enhanced secretion of hUII by the injured tubules. Thus, a significant amount of hUII-LI excreted in human urine is likely to be derived from the renal tubular cells. These observations, together with the present results, lead us to speculate that UII secreted from renal tubules may act on tubular cells to repair at the site of tubular injury in an autocrine/paracrine fashion.
In conclusion, we have demonstrated that UII is an autocrine/paracrine growth factor for renal epithelial cell line (LLCPK1) via activation of both PKC and ERK1/2 pathways as well as Ca 2ϩ influx via DHP-sensitive Ca 2ϩ channels. However, the physiological and pathophysiological roles of UII in renal tissues remain to be determined.
